• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

4DMedical Invests $3.4M in RevealDx to Build a Connected Cardiopulmonary Platform

by Jasmine Pennic 08/05/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
4DMedical Invests $3.4M in RevealDx to Build a Connected Cardiopulmonary Platform

What You Should Know

  • Seattle-based RevealDx has secured a $3.4M strategic investment and a global distribution agreement with Melbourne-listed 4DMedical.
  • The agreement appoints 4DMedical as the distributor for RevealDx’s flagship software, RevealAI-Lung, across the United States, Europe, Australia, and New Zealand.
  • RevealAI-Lung is an AI CADx software that generates a Malignancy Similarity Index (mSI™) to characterize incidental lung nodules, validated on over 1,500 patients.
  • The tool has achieved full regulatory triad clearance (US FDA clearance, European MDR certification, and Australian TGA approval) and is reimbursable by U.S. Medicare under CPT codes 0721T and 0722T.
  • The move follows 4DMedical’s acquisition of Austrian chest CT company contextflow, into whose platform RevealAI-Lung has already been integrated and deployed at several European clinical sites.

Bypassing Fragmented Radiology Workflows: RevealAI-Lung Integrates into PACS and contextflow

4DMedical has made a $3.4M strategic investment in RevealDx, securing exclusive global distribution rights for its RevealAI-Lung software to build out an integrated, PACS-native cardiopulmonary imaging platform. Chestnut Partners, Inc. served as the exclusive financial advisor to RevealDx for the transaction.

The partnership targets a persistent bottleneck in enterprise radiology: managing incidental lung nodules detected on chest CT scans. While incidental findings are common, accurately characterizing malignancy risk without generating excessive false positives or disrupting radiologist productivity remains a primary operational hurdle for health systems.

RevealDx’s software, RevealAI-Lung, addresses this challenge by generating a Malignancy Similarity Index (mSI™) based on real-world reference data from the National Lung Screening Trial. The algorithm stratifies risk across more than 1,500 patient cohorts to help radiologists distinguish benign nodules from early-stage lung cancers. The software holds FDA clearance, European MDR certification, and Australian TGA approval, and is backed by existing U.S. Medicare coverage under CPT codes 0721T and 0722T.

Under the global distribution agreement, 4DMedical will embed RevealAI-Lung directly into its newly acquired contextflow chest CT platform and pair it with its proprietary CT:VQ™ ventilation-perfusion functional imaging software. By integrating anatomical nodule detection, AI risk scoring, and functional lung physiology into a single PACS interface, the combined stack allows health systems to automate risk stratification without forcing clinicians to navigate standalone software applications.

Andreas Fouras, Founder and CEO of 4DMedical, emphasized the focus on platform integration: “For 4DMedical, this is about more than adding products. It is about building a connected ecosystem for cardiopulmonary care. CT:VQ™ gives physicians physiological insight into how the lung is actually functioning. By surrounding that capability with disease detection, and AI-powered risk stratification, we can help health systems identify the right patients earlier and ensure they receive appropriate care.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |